Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 17 Neoplasms 9 Polycystic Ovary Syndrome 7 Multiple Myeloma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1

Interventions

rozanolixizumab 9 efgartigimod alfa 9 Prednisone 8 zilucoplan 7 Pyridostigmine Bromide 7 Tacrolimus 6 Rituximab 6 Cyclophosphamide 6 telitacicept 5 ravulizumab 5 eculizumab 5 fludarabine 4 Mycophenolic Acid 4 Hizentra 4 Steroids 3 Immunoglobulins, Intravenous 3 HBM9161 3 Azathioprine 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Data Collection 2 Blood Specimen Collection 2 tofacitinib 1 tocilizumab 1 satralizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03914638 2020-04-06

BETA-MG

University of Aarhus

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡